We found that the MAP17-dependent increase in sensitivity in sarcoma was correlated with lower levels of phosphorylated NFκB and autophagy measured as p62/LC3II, further supporting the relevance of these two pathways in MAP17 increased sensitivity. Here, PDZK1IP1 is linked to sarcoma.